SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-013783
Filing Date
2023-04-27
Accepted
2023-04-27 09:17:20
Documents
14
Period of Report
2023-04-27
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63042
2 ex3-1.htm EX-3.1 14071
3 ex3-2.htm EX-3.2 116579
  Complete submission text file 0001493152-23-013783.txt   404311

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE prvb-20230427.xsd EX-101.SCH 3242
5 XBRL LABEL FILE prvb-20230427_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE prvb-20230427_pre.xml EX-101.PRE 22799
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3881
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38552 | Film No.: 23852284
SIC: 2834 Pharmaceutical Preparations